NF-kappaB Pathway Inhibition Targeted Anti-Inflammatory Control KPV provides potent anti-inflammatory effects through direct inhibition of nuclear factor-kappa B (NF-kappaB), distinguishing KLOW from GLOW through enhanced inflammation control[3]: Competitive blocking of importin-alpha3 interaction with NF-kappaB p65/RelA subunit Prevention of NF-kappaB nuclear translocation in activated cells Inhibition of pro-inflammatory gene transcription Reduction of cytokine production including TNF-alpha, IL-1beta, and IL-6 PepT1-mediated cellular uptake enabling intracellular anti-inflammatory action This mechanism operates at nanomolar concentrations and works through a melanocortin receptor-independent pathway, providing inflammation control without hormonal side effects while complementing the other components regenerative actions
This product is supplied strictly for lawful laboratory research purposes only
In addition, this response was unchanged in the presence of -Glu-Glu, suggesting no direct additive action of glycine and -Glu-Glu on glutamate-mediated actions under these conditions
CCL2 is a tiny cytokine that has the ability to cause inflammation
Together, they improve mitochondrial function, neutralize free radicals, and support overall cellular health